Ishares Us Pharmaceuticals Etf ETF Forecast

Buy or Hold candidate since May 21, 2026 Gain 11.13%

The iShares US Pharmaceuticals ETF price fell by -1.67% on the last day (Friday, 10th Jul 2026) from $102.22 to $100.51. It has now fallen 3 days in a row. During the last trading day the ETF fluctuated 2.42% from a day low at $99.97 to a day high of $102.39. The price has fallen in 6 of the last 10 days but is still up by 4.76% over the past 2 weeks. Volume has increased on the last day by 33 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $104.56 million.

The ETF lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 16.36% during the next 3 months and, with a 90% probability hold a price between $110.81 and $121.18 at the end of this 3-month period.

IHE Signals & Forecast

The iShares US Pharmaceuticals ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $101.15. On a fall, the ETF will find some support from the long-term average at approximately $94.81. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -2.81%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the ETF should be followed more closely.

Support, Risk & Stop-loss for iShares US Pharmaceuticals ETF

iShares US Pharmaceuticals finds support from accumulated volume at $95.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the ETF moved $2.42 between high and low, or 2.42%. For the last week, the ETF has had daily average volatility of 1.43%.

Our recommended stop-loss: $96.98 (-3.52%) (This ETF has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (IHE) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect iShares US Pharmaceuticals ETF to open at $100.96, and during the day (based on 14 day Average True Range), to move between $99.60 and $101.42, which gives a possible trading interval of +/-$1.83 (+/-1.84%) up or down from last closing price. If iShares US Pharmaceuticals ETF takes out the full calculated possible swing range there will be an estimated 1.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $100.96 (0.45%) than the support at $95.94 (4.55%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is iShares US Pharmaceuticals ETF ETF A Buy?

iShares US Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Hold candidate.

Current score: 0.796 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $100.96 ( 0.443%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk